Shop Apotheke Europe N.V. (SAEYY)
USD 15.6
(0.0%)
USD 15.6
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 50.93 Million EUR | 222.01% |
| 2022 | -36.1 Million EUR | -66.94% |
| 2021 | -19.9 Million EUR | -281.91% |
| 2020 | 10.89 Million EUR | 153.56% |
| 2019 | -19.83 Million EUR | -34.12% |
| 2018 | -17.97 Million EUR | -25.92% |
| 2017 | -12.09 Million EUR | -44.9% |
| 2016 | -8.34 Million EUR | -37.77% |
| 2015 | -6.06 Million EUR | -153.34% |
| 2014 | -2.39 Million EUR | -218.09% |
| 2013 | -752 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 13.88 Million EUR | 31.27% |
| 2024 Q1 | 10.55 Million EUR | 144.19% |
| 2023 Q4 | -5.05 Million EUR | -119.17% |
| 2023 FY | - EUR | 222.01% |
| 2023 Q3 | 26.37 Million EUR | 119.72% |
| 2023 Q1 | 5.34 Million EUR | 157.65% |
| 2023 Q2 | 12 Million EUR | 124.79% |
| 2022 Q1 | -10.29 Million EUR | 73.29% |
| 2022 FY | - EUR | -66.94% |
| 2022 Q4 | -9.26 Million EUR | -66.88% |
| 2022 Q3 | -5.55 Million EUR | 49.55% |
| 2022 Q2 | -11 Million EUR | -6.87% |
| 2021 Q2 | -1.89 Million EUR | -160.22% |
| 2021 Q4 | -38.53 Million EUR | -659.21% |
| 2021 Q1 | 3.14 Million EUR | 270.92% |
| 2021 FY | - EUR | -281.91% |
| 2021 Q3 | -5.07 Million EUR | -167.95% |
| 2020 Q4 | -1.84 Million EUR | -163.67% |
| 2020 Q2 | 5.55 Million EUR | 41.02% |
| 2020 Q3 | 2.89 Million EUR | -47.98% |
| 2020 Q1 | 3.94 Million EUR | 168.62% |
| 2020 FY | - EUR | 153.56% |
| 2019 Q2 | -3.42 Million EUR | 54.56% |
| 2019 FY | - EUR | -34.12% |
| 2019 Q3 | -3.11 Million EUR | 9.04% |
| 2019 Q4 | -5.74 Million EUR | -84.16% |
| 2019 Q1 | -7.54 Million EUR | -43.8% |
| 2018 Q2 | -2.34 Million EUR | 52.57% |
| 2018 Q1 | -4.94 Million EUR | 7.27% |
| 2018 Q3 | -2.69 Million EUR | -14.96% |
| 2018 Q4 | -5.24 Million EUR | -94.51% |
| 2018 FY | - EUR | -25.92% |
| 2017 Q1 | -3.53 Million EUR | -0.77% |
| 2017 FY | - EUR | -44.9% |
| 2017 Q2 | -1.38 Million EUR | 60.75% |
| 2017 Q3 | -1.83 Million EUR | -32.18% |
| 2017 Q4 | -5.33 Million EUR | -190.52% |
| 2016 Q1 | -2.25 Million EUR | 14.37% |
| 2016 Q4 | -3.51 Million EUR | -147.85% |
| 2016 Q3 | -1.41 Million EUR | -21.84% |
| 2016 Q2 | -1.16 Million EUR | 48.49% |
| 2016 FY | - EUR | -37.77% |
| 2015 Q1 | -1.01 Million EUR | 0.0% |
| 2015 FY | - EUR | -153.34% |
| 2015 Q3 | -1.63 Million EUR | -61.04% |
| 2015 Q4 | -2.63 Million EUR | -61.09% |
| 2015 Q2 | -1.01 Million EUR | 0.0% |
| 2014 FY | - EUR | -218.09% |
| 2013 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | 20285234.005% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | 21167.303% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | 43.023% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | 3699.106% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -47.95 Thousand USD | 106313.77% |
| HealthWarehouse.com, Inc. | -1.27 Million USD | 4094.176% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | -7.846% |
| MedGen, Inc. | -15.37 USD | 331411941.249% |
| Omni Health, Inc. | 1.28 Million USD | -3856.048% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | 14909.022% |
| Pineapple, Inc. | -1.47 Million USD | 3552.773% |
| ScripsAmerica, Inc. | -3.95 Million USD | 1388.113% |